Suppr超能文献

纳米医学人体研究监督建议:新兴领域的演进方法。

Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.

机构信息

University of Minnesota, MN, USA.

出版信息

J Law Med Ethics. 2012 Winter;40(4):716-50. doi: 10.1111/j.1748-720X.2012.00703.x.

Abstract

The nanomedicine field is fast evolving toward complex, "active," and interactive formulations. Like many emerging technologies, nanomedicine raises questions of how human subjects research (HSR) should be conducted and the adequacy of current oversight, as well as how to integrate concerns over occupational, bystander, and environmental exposures. The history of oversight for HSR investigating emerging technologies is a patchwork quilt without systematic justification of when ordinary oversight for HSR is enough versus when added oversight is warranted. Nanomedicine HSR provides an occasion to think systematically about appropriate oversight, especially early in the evolution of a technology, when hazard and risk information may remain incomplete. This paper presents the consensus recommendations of a multidisciplinary, NIH-funded project group, to ensure a science-based and ethically informed approach to HSR issues in nanomedicine, and to integrate HSR analysis with analysis of occupational, bystander, and environmental concerns. We recommend creating two bodies, an interagency Human Subjects Research in Nanomedicine (HSR/N) Working Group and a Secretary's Advisory Committee on Nanomedicine (SAC/N). HSR/N and SAC/N should perform 3 primary functions: (1) analysis of the attributes and subsets of nanomedicine interventions that raise HSR challenges and current gaps in oversight; (2) providing advice to relevant agencies and institutional bodies on the HSR issues, as well as federal and federal-institutional coordination; and (3) gathering and analyzing information on HSR issues as they emerge in nanomedicine. HSR/N and SAC/N will create a home for HSR analysis and coordination in DHHS (the key agency for relevant HSR oversight), optimize federal and institutional approaches, and allow HSR review to evolve with greater knowledge about nanomedicine interventions and greater clarity about attributes of concern.

摘要

纳米医学领域正在快速向复杂、“主动”和互动的制剂发展。像许多新兴技术一样,纳米医学提出了如何进行人类受试者研究(HSR)以及当前监督的充分性问题,以及如何整合对职业、旁观者和环境暴露的关注。监督新兴技术 HSR 的历史是一块拼凑的拼布被子,没有系统地证明 HSR 的普通监督何时足够,何时需要额外的监督。纳米医学 HSR 提供了一个系统思考适当监督的机会,特别是在技术发展的早期阶段,此时危险和风险信息可能仍然不完整。本文介绍了一个多学科、NIH 资助的项目组的共识建议,以确保纳米医学 HSR 问题采取基于科学和伦理知情的方法,并将 HSR 分析与职业、旁观者和环境问题的分析相结合。我们建议创建两个机构,一个是机构间人类受试者研究纳米医学(HSR/N)工作组和一个秘书纳米医学咨询委员会(SAC/N)。HSR/N 和 SAC/N 应履行 3 项主要职能:(1)分析提出 HSR 挑战和监督当前差距的纳米医学干预措施的属性和子集;(2)就 HSR 问题向相关机构和机构提供建议,以及联邦和联邦机构的协调;(3)在纳米医学中出现 HSR 问题时收集和分析信息。HSR/N 和 SAC/N 将为 DHHS(相关 HSR 监督的主要机构)中的 HSR 分析和协调创造一个家,优化联邦和机构方法,并允许 HSR 审查随着对纳米医学干预措施的更多了解和对关注属性的更清晰认识而发展。

相似文献

2
Concepts of risk in nanomedicine research.纳米医学研究中的风险概念。
J Law Med Ethics. 2012 Winter;40(4):809-22. doi: 10.1111/j.1748-720X.2012.00709.x.
8
A portrait of nanomedicine and its bioethical implications.纳米医学及其生物伦理学影响的画像。
J Law Med Ethics. 2012 Winter;40(4):763-79. doi: 10.1111/j.1748-720X.2012.00705.x.
9
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.

本文引用的文献

3
Ethics and Nanopharmacy: Value Sensitive Design of New Drugs.伦理与纳米药学:新药的价值敏感设计
Nanoethics. 2011 Dec;5(3):269-283. doi: 10.1007/s11569-011-0135-x. Epub 2011 Nov 9.
4
Don't define nanomaterials.不要定义纳米材料。
Nature. 2011 Jul 6;475(7354):31. doi: 10.1038/475031a.
7
Regulating nanomedicine - can the FDA handle it?规范纳米医学——FDA 能应对吗?
Curr Drug Deliv. 2011 May;8(3):227-34. doi: 10.2174/156720111795256156.
8
The new toxicology of sophisticated materials: nanotoxicology and beyond.复杂材料的新毒理学:纳米毒理学及其他。
Toxicol Sci. 2011 Mar;120 Suppl 1(Suppl 1):S109-29. doi: 10.1093/toxsci/kfq372. Epub 2010 Dec 22.
9
Debunking some misconceptions about nanotoxicology.破除纳米毒理学的一些误区。
Nano Lett. 2010 Dec 8;10(12):4777-82. doi: 10.1021/nl103432w. Epub 2010 Oct 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验